Table of Contents Chapter 1 Biologics and Biosimilars Market Overview 1.1 Biologics and Biosimilars Definition 1.2 Global Biologics and Biosimilars Market Size Status and Outlook (2014-2029) 1.3 Global Biologics and Biosimilars Market Size Comparison by Region (2014-2029) 1.4 Global Biologics and Biosimilars Market Size Comparison by Type (2014-2029) 1.5 Global Biologics and Biosimilars Market Size Comparison by Application (2014-2029) 1.6 Global Biologics and Biosimilars Market Size Comparison by Sales Channel (2014-2029) 1.7 Biologics and Biosimilars Market Dynamics (COVID-19 Impacts) 1.7.1 Market Drivers/Opportunities 1.7.2 Market Challenges/Risks 1.7.3 Market News (Mergers/Acquisitions/Expansion) 1.7.4 COVID-19 Impacts on Current Market 1.7.5 Post-Strategies of COVID-19 Outbreak Chapter 2 Biologics and Biosimilars Market Segment Analysis by Player 2.1 Global Biologics and Biosimilars Sales and Market Share by Player (2017-2019) 2.2 Global Biologics and Biosimilars Revenue and Market Share by Player (2017-2019) 2.3 Global Biologics and Biosimilars Average Price by Player (2017-2019) 2.4 Players Competition Situation & Trends 2.5 Conclusion of Segment by Player Chapter 3 Biologics and Biosimilars Market Segment Analysis by Type 3.1 Global Biologics and Biosimilars Market by Type 3.1.1 Monoclonal Antibodies 3.1.2 Interferon 3.1.3 Erythropoietin 3.1.4 Insulin 3.1.5 Vaccines 3.2 Global Biologics and Biosimilars Sales and Market Share by Type (2014-2019) 3.3 Global Biologics and Biosimilars Revenue and Market Share by Type (2014-2019) 3.4 Global Biologics and Biosimilars Average Price by Type (2014-2019) 3.5 Leading Players of Biologics and Biosimilars by Type in 2019 3.6 Conclusion of Segment by Type Chapter 4 Biologics and Biosimilars Market Segment Analysis by Application 4.1 Global Biologics and Biosimilars Market by Application 4.1.1 Tumor 4.1.2 Diabetes 4.1.3 Cardiovascular 4.1.4 Hemophilia 4.1.5 Other 4.2 Global Biologics and Biosimilars Sales and Market Share by Application (2014-2019) 4.3 Leading Consumers of Biologics and Biosimilars by Application in 2019 4.4 Conclusion of Segment by Application Chapter 5 Biologics and Biosimilars Market Segment Analysis by Sales Channel 5.1 Global Biologics and Biosimilars Market by Sales Channel 5.1.1 Direct Channel 5.1.2 Distribution Channel 5.2 Global Biologics and Biosimilars Sales and Market Share by Sales Channel (2014-2019) 5.3 Leading Distributors/Dealers of Biologics and Biosimilars by Sales Channel in 2019 5.4 Conclusion of Segment by Sales Channel Chapter 6 Biologics and Biosimilars Market Segment Analysis by Region 6.1 Global Biologics and Biosimilars Market Size and CAGR by Region (2014-2029) 6.2 Global Biologics and Biosimilars Sales and Market Share by Region (2014-2019) 6.3 Global Biologics and Biosimilars Revenue and Market Share by Region (2014-2019) 6.4 North America 6.4.1 North America Market by Country 6.4.2 North America Biologics and Biosimilars Market Share by Type 6.4.3 North America Biologics and Biosimilars Market Share by Application 6.4.4 United States 6.4.5 Canada 6.4.6 Mexico 6.5 Europe 6.5.1 Europe Market by Country 6.5.2 Europe Biologics and Biosimilars Market Share by Type 6.5.3 Europe Biologics and Biosimilars Market Share by Application 6.5.4 Germany 6.5.5 UK 6.5.6 France 6.5.7 Italy 6.5.8 Russia 6.5.9 Spain 6.6 Asia-Pacific 6.6.1 Asia-Pacific Market by Country 6.6.2 Asia-Pacific Biologics and Biosimilars Market Share by Type 6.6.3 Asia-Pacific Biologics and Biosimilars Market Share by Application 6.6.4 China 6.6.5 Japan 6.6.6 Korea 6.6.7 India 6.6.8 Southeast Asia 6.6.9 Australia 6.7 South America 6.7.1 South America Market by Country 6.7.2 South America Biologics and Biosimilars Market Share by Type 6.7.3 South America Biologics and Biosimilars Market Share by Application 6.7.4 Brazil 6.7.5 Argentina 6.7.6 Colombia 6.8 Middle East & Africa 6.8.1 Middle East & Africa Market by Country 6.8.2 Middle East & Africa Biologics and Biosimilars Market Share by Type 6.8.3 Middle East & Africa Biologics and Biosimilars Market Share by Application 6.8.4 UAE 6.8.5 Saudi Arabia 6.8.6 South Africa 6.9 Conclusion of Segment by Region Chapter 7 Profile of Leading Biologics and Biosimilars Players 7.1 Roche 7.1.1 Company Snapshot 7.1.2 Product/Service Offered 7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share) 7.1.4 COVID-19 Impact on Roche 7.2 Amgen 7.3 AbbVie 7.4 Sanofi-Aventis 7.5 Johnson & Johnson 7.6 Pfizer 7.7 Novo Nordisk 7.8 Eli Lilly 7.9 Novartis 7.10 Merck 7.11 3sbio 7.12 Changchun High Tech 7.13 CP Guojian 7.14 Biotech 7.15 Gelgen 7.16 Innovent 7.17 Dong Bao 7.18 Ganlee Chapter 8 Upstream and Downstream Analysis of Biologics and Biosimilars 8.1 Industrial Chain of Biologics and Biosimilars 8.2 Upstream of Biologics and Biosimilars 8.2.1 Raw Materials 8.2.2 Labor Cost 8.2.3 Manufacturing Expenses 8.2.4 Manufacturing Cost Structure 8.2.5 Manufacturing Process 8.3 Downstream of Biologics and Biosimilars 8.3.1 Leading Distributors/Dealers of Biologics and Biosimilars 8.3.2 Leading Consumers of Biologics and Biosimilars Chapter 9 Development Trend of Biologics and Biosimilars (2020-2029) 9.1 Global Biologics and Biosimilars Market Size (Sales and Revenue) Forecast (2020-2029) 9.2 Global Biologics and Biosimilars Market Size and CAGR Forecast by Region (2020-2029) 9.3 Global Biologics and Biosimilars Market Size and CAGR Forecast by Type (2020-2029) 9.4 Global Biologics and Biosimilars Market Size and CAGR Forecast by Application (2020-2029) 9.5 Global Biologics and Biosimilars Market Size and CAGR Forecast by Sales Channel (2020-2029) Chapter 10 Appendix 10.1 Research Methodology 10.2 Data Sources 10.3 Disclaimer 10.4 Analysts Certification

List of Tables and Figures Figure Biologics and Biosimilars Example Figure Global Biologics and Biosimilars Revenue (Million $) Status and Outlook (2014-2029) Figure Global Biologics and Biosimilars Revenue (Million $) Comparison by Region (2014-2029) Figure Global Biologics and Biosimilars Sales Comparison by Type (2014-2029) Figure Global Biologics and Biosimilars Sales Comparison by Application (2014-2029) Figure Global Biologics and Biosimilars Sales Comparison by Sales Channel (2014-2029) Table Global Biologics and Biosimilars Sales by Player (2017-2019) Table Global Biologics and Biosimilars Sales Market Share by Player (2017-2019) Figure Global Biologics and Biosimilars Sales Market Share by Player in 2019 Table Global Biologics and Biosimilars Revenue (Million $) by Player (2017-2019) Table Global Biologics and Biosimilars Revenue Market Share by Player (2017-2019) Figure Global Biologics and Biosimilars Revenue Market Share by Player in 2019 Table Global Biologics and Biosimilars Average Price by Player (2017-2019) Figure Global Biologics and Biosimilars Average Price by Player in 2019 Figure Global Biologics and Biosimilars Players Competition Situation – Top 5 Players’ Revenue Market Share in 2017 Figure Global Biologics and Biosimilars Players Competition Trends – Top 5 Players’ Revenue Market Share in 2019 Figure Example of Monoclonal Antibodies Figure Global Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure Example of Interferon Figure Global Interferon Sales and Growth Rate (2014-2019) Figure Example of Erythropoietin Figure Global Erythropoietin Sales and Growth Rate (2014-2019) Figure Example of Insulin Figure Global Insulin Sales and Growth Rate (2014-2019) Figure Example of Vaccines Figure Global Vaccines Sales and Growth Rate (2014-2019) Table Global Biologics and Biosimilars Sales by Type (2014-2019) Table Global Biologics and Biosimilars Sales Market Share by Type (2014-2019) Figure Global Biologics and Biosimilars Sales Market Share by Type in 2019 Table Global Biologics and Biosimilars Revenue (Million $) by Type (2014-2019) Table Global Biologics and Biosimilars Revenue Market Share by Type (2014-2019) Figure Global Biologics and Biosimilars Revenue Market Share by Type in 2019 Table Global Biologics and Biosimilars Average Price by Type (2014-2019) Figure Global Biologics and Biosimilars Average Price by Type in 2019 Table Leading Players of Biologics and Biosimilars by Type in 2019 Figure Example of Tumor Figure Global Biologics and Biosimilars for Tumor Sales and Growth Rate (2014-2019) Figure Example of Diabetes Figure Global Biologics and Biosimilars for Diabetes Sales and Growth Rate (2014-2019) Figure Example of Cardiovascular Figure Global Biologics and Biosimilars for Cardiovascular Sales and Growth Rate (2014-2019) Figure Example of Hemophilia Figure Global Biologics and Biosimilars for Hemophilia Sales and Growth Rate (2014-2019) Figure Example of Other Figure Global Biologics and Biosimilars for Other Sales and Growth Rate (2014-2019) Table Global Biologics and Biosimilars Sales by Application (2014-2019) Table Global Biologics and Biosimilars Sales Market Share by Application (2014-2019) Figure Global Biologics and Biosimilars Sales Market Share by Application in 2019 Table Leading Consumers of Biologics and Biosimilars by Application in 2019 Figure Example of Direct Channel Figure Global Biologics and Biosimilars for Direct Channel Sales and Growth Rate (2014-2019) Figure Example of Distribution Channel Figure Global Biologics and Biosimilars for Distribution Channel Sales and Growth Rate (2014-2019) Table Global Biologics and Biosimilars Sales by Sales Channel (2014-2019) Table Global Biologics and Biosimilars Sales Market Share by Sales Channel (2014-2019) Figure Global Biologics and Biosimilars Sales Market Share by Sales Channel in 2019 Table Leading Distributors/Dealers of Biologics and Biosimilars by Sales Channel in 2019 Table Global Biologics and Biosimilars Market Size and CAGR by Region (2014-2029) Table Global Biologics and Biosimilars Sales by Region (2014-2019) Table Global Biologics and Biosimilars Sales Market Share by Region (2014-2019) Figure Global Biologics and Biosimilars Sales Market Share by Region in 2019 Table Global Biologics and Biosimilars Revenue (Million $) by Region (2014-2019) Table Global Biologics and Biosimilars Revenue Market Share by Region (2014-2019) Figure Global Biologics and Biosimilars Revenue Market Share by Region in 2019 Table North America Biologics and Biosimilars Sales by Country (2014-2019) Figure North America Biologics and Biosimilars Sales Market Share by Country (2014-2019) Table North America Biologics and Biosimilars Revenue by Country (2014-2019) Figure North America Biologics and Biosimilars Revenue Market Share by Country (2014-2019) Figure North America Biologics and Biosimilars Sales Market Share by Type in 2019 Figure North America Biologics and Biosimilars Sales Market Share by Application in 2019 Figure United States Biologics and Biosimilars Sales and Growth Rate (2014-2019) Figure United States Biologics and Biosimilars Revenue (Million $) and Growth Rate (2014-2019) Figure Canada Biologics and Biosimilars Sales and Growth Rate (2014-2019) Figure Canada Biologics and Biosimilars Revenue (Million $) and Growth Rate (2014-2019) Figure Mexico Biologics and Biosimilars Sales and Growth Rate (2014-2019) Figure Mexico Biologics and Biosimilars Revenue (Million $) and Growth Rate (2014-2019) Table Europe Biologics and Biosimilars Sales by Country (2014-2019) Figure Europe Biologics and Biosimilars Sales Market Share by Country (2014-2019) Table Europe Biologics and Biosimilars Revenue by Country (2014-2019) Figure Europe Biologics and Biosimilars Revenue Market Share by Country (2014-2019) Figure Europe Biologics and Biosimilars Sales Market Share by Type in 2019 Figure Europe Biologics and Biosimilars Sales Market Share by Application in 2019 Figure Germany Biologics and Biosimilars Sales and Growth Rate (2014-2019) Figure Germany Biologics and Biosimilars Revenue (Million $) and Growth Rate (2014-2019) Figure UK Biologics and Biosimilars Sales and Growth Rate (2014-2019) Figure UK Biologics and Biosimilars Revenue (Million $) and Growth Rate (2014-2019) Figure France Biologics and Biosimilars Sales and Growth Rate (2014-2019) Figure France Biologics and Biosimilars Revenue (Million $) and Growth Rate (2014-2019) Figure Italy Biologics and Biosimilars Sales and Growth Rate (2014-2019) Figure Italy Biologics and Biosimilars Revenue (Million $) and Growth Rate (2014-2019) Figure Russia Biologics and Biosimilars Sales and Growth Rate (2014-2019) Figure Russia Biologics and Biosimilars Revenue (Million $) and Growth Rate (2014-2019) Figure Spain Biologics and Biosimilars Sales and Growth Rate (2014-2019) Figure Spain Biologics and Biosimilars Revenue (Million $) and Growth Rate (2014-2019) Table Asia-Pacific Biologics and Biosimilars Sales by Country (2014-2019) Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Country (2014-2019) Table Asia-Pacific Biologics and Biosimilars Revenue by Country (2014-2019) Figure Asia-Pacific Biologics and Biosimilars Revenue Market Share by Country (2014-2019) Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Type in 2019 Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Application in 2019 Figure China Biologics and Biosimilars Sales and Growth Rate (2014-2019) Figure China Biologics and Biosimilars Revenue (Million $) and Growth Rate (2014-2019) Figure Japan Biologics and Biosimilars Sales and Growth Rate (2014-2019) Figure Japan Biologics and Biosimilars Revenue (Million $) and Growth Rate (2014-2019) Figure Korea Biologics and Biosimilars Sales and Growth Rate (2014-2019) Figure Korea Biologics and Biosimilars Revenue (Million $) and Growth Rate (2014-2019) Figure India Biologics and Biosimilars Sales and Growth Rate (2014-2019) Figure India Biologics and Biosimilars Revenue (Million $) and Growth Rate (2014-2019) Figure Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2014-2019) Figure Southeast Asia Biologics and Biosimilars Revenue (Million $) and Growth Rate (2014-2019) Figure Australia Biologics and Biosimilars Sales and Growth Rate (2014-2019) Figure Australia Biologics and Biosimilars Revenue (Million $) and Growth Rate (2014-2019) Table South America Biologics and Biosimilars Sales by Country (2014-2019) Figure South America Biologics and Biosimilars Sales Market Share by Country (2014-2019) Table South America Biologics and Biosimilars Revenue by Country (2014-2019) Figure South America Biologics and Biosimilars Revenue Market Share by Country (2014-2019) Figure South America Biologics and Biosimilars Sales Market Share by Type in 2019 Figure South America Biologics and Biosimilars Sales Market Share by Application in 2019 Figure Brazil Biologics and Biosimilars Sales and Growth Rate (2014-2019) Figure Brazil Biologics and Biosimilars Revenue (Million $) and Growth Rate (2014-2019) Figure Argentina Biologics and Biosimilars Sales and Growth Rate (2014-2019) Figure Argentina Biologics and Biosimilars Revenue (Million $) and Growth Rate (2014-2019) Figure Colombia Biologics and Biosimilars Sales and Growth Rate (2014-2019) Figure Colombia Biologics and Biosimilars Revenue (Million $) and Growth Rate (2014-2019) Table Middle East & Africa Biologics and Biosimilars Sales by Country (2014-2019) Figure Middle East & Africa Biologics and Biosimilars Sales Market Share by Country (2014-2019) Table Middle East & Africa Biologics and Biosimilars Revenue by Country (2014-2019) Figure Middle East & Africa Biologics and Biosimilars Revenue Market Share by Country (2014-2019) Figure Middle East & Africa Biologics and Biosimilars Sales Market Share by Type in 2019 Figure Middle East & Africa Biologics and Biosimilars Sales Market Share by Application in 2019 Figure UAE Biologics and Biosimilars Sales and Growth Rate (2014-2019) Figure UAE Biologics and Biosimilars Revenue (Million $) and Growth Rate (2014-2019) Figure Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2014-2019) Figure Saudi Arabia Biologics and Biosimilars Revenue (Million $) and Growth Rate (2014-2019) Figure South Africa Biologics and Biosimilars Sales and Growth Rate (2014-2019) Figure South Africa Biologics and Biosimilars Revenue (Million $) and Growth Rate (2014-2019) Table Company Snapshot of Roche Table Biologics and Biosimilars Introduction of Roche Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share of Roche (2017-2019) Table Industrial Chain of Biologics and Biosimilars Table Manufacturing Cost Structure of Biologics and Biosimilars Table General Manufacturing Process of Biologics and Biosimilars Table Leading Distributors/Dealers of Biologics and Biosimilars Table Leading Consumers of Biologics and Biosimilars Figure Global Biologics and Biosimilars Sales and Growth Rate Forecast (2020-2029) Figure Global Biologics and Biosimilars Revenue and Growth Rate Forecast (2020-2029) Table Global Biologics and Biosimilars Market Size and CAGR Forecast by Region (2020-2029) Table Global Biologics and Biosimilars Market Size and CAGR Forecast by Type (2020-2029) Table Global Biologics and Biosimilars Market Size and CAGR Forecast by Application (2020-2029) Table Global Biologics and Biosimilars Market Size and CAGR Forecast by Sales Channel (2020-2029)

Roche Amgen AbbVie Sanofi-Aventis Johnson & Johnson Pfizer Novo Nordisk Eli Lilly Novartis Merck 3sbio Changchun High Tech CP Guojian Biotech Gelgen Innovent Dong Bao Ganlee